From the News Desk of Jeanne Hambleton

Courtesy of Hays Pharma posted 09 Mar 2009

Forest Labs and Cypress Bioscience have delayed the release of its fibromyalgia treatment onto the market after it submitted a post-approval application to the US Food and Drug Administration (FDA).

The treatment, Savella, was originally expected to be shipped out to wholesalers and pharmacies in March, but the company now expects that it will be available in mid 2009.

Forest and Cypress have applied to the FDA for authorisation of a cosmetic formulation change and expects a response from the agency no later than May.

US health authorities originally approved the serotonin and norepinephrine reuptake inhibitor on January 14th for the management of fibromyalgia, a chronic condition characterised by widespread pain and reduced physical function.

A US court has recently filed a complaint against Forest, alleging that the company’s personnel falsely marketed the antidepressants Lexapro and Celexa and paid kickbacks to physicians to persuade them to prescribe the drugs.

Forest states that it is reviewing the allegations and will respond to the action at the appropriate time.

About jeanne hambleton

Journalist-wordsmith, former reporter, columnist, film critic, editor, Town Clerk and then fibromite and eventer with 5 conferences done and dusted. Interested in all health and well being issues, passionate about research to find a cure and cause for fibromyalgia. Member LinkedIn. Worked for 4 years with FMA UK as Regional Coordinator for SW and SE,and Chair for FMS SAS the Sussex and Surrey FM umbrella charity and Chair Folly Pogs Fibromyalgia Research UK - finding funding for our "cause for a cure" and President and co ordinator of National FM Conferences. Just finished last national annual Fibromyalgia Conference Weekend. This was another success with speakers from the States . Next year's conference in Chichester Park Hotel, West Sussex, will be April 24/27 2015 and bookings are coming in from those who raved about the event every year. I am very busy but happy to produce articles for publication. News Editor of FMS Global News on line but a bit behind due to conference. A workaholic beyond redemption! The future - who knows? Open to offers with payment. Versatile and looking for a regular paid column - you call the tune and I will play the pipes.
This entry was posted in 13606, 16816416, 16816701, Drugs, feed://, Feeds, Fibrohugs, Fibrohugs News, Fibromyalgia, Fibromyalgia Blogs, Fibromyalgia News, Fibromyalgia News Southeast Asia, Fibromyalgia News UK, Fibromyalgia Press Releases, FM, FM drug companies, FMS, FMS Global News, Global News, Health,,,, Jeanne Hambleton, Journalist UK, London, London UK, London UK Feed, Medical, Medical Research, News, News UK, Pharmacologic, Pharmacological, RSS, RSS Feeds, Tenderpoints, UK feeds and tagged , , , , , , , , , , , , , , , , , , , , , , , , , . Bookmark the permalink.

Leave a Reply

Please log in using one of these methods to post your comment: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s